JAGUAR HEALTH, INC. Stock Issued During Period, Shares, Issued for Services
JAGUAR HEALTH, INC. (JAGX) reported Stock Issued During Period, Shares, Issued for Services of 40.00 thousand shares for the 1-month period ending 2019-10-31, per its 10-K filed 2020-04-03.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesIssuedForServices · last filed 2020-04-03
- 2019-10-31: Stock Issued During Period, Shares, Issued for Services 1 month 40.00K shares.
- 2013-06-11: Stock Issued During Period, Shares, Issued for Services 2.67M shares.
| Period end | Stock Issued During Period, Shares, Issued for Services | Stock Issued During Period, Shares, Issued for Services 1 month |
|---|---|---|
| 2019-10-31 | 40.00K shares 10-K · filed 2020-04-03 | |
| 2013-06-11 | 2.67M shares 10-Q · filed 2018-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |